CLASS II ONGOING Drug recall · Reported 30 Apr 2025 · FDA Enforcement Report

Hemopropin Ointment, Lanolin 17.76% and Petrolatum recalled by Apipharma

Apipharma is recalling Hemopropin Ointment, Lanolin 17.76% and Petrolatum 71.2%, distributed in Arizona. The recall was initiated on 9 Apr 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: A00001, Exp.: 2027-12; A00005, Exp.: 2027-01; B00001, Exp.:2028-02
Quantity recalled4,218 boxes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0375-2025
FDA event ID
96601
Recalling firm
Apipharma, Zagreb, N/A
Classification
Class II
Status
Ongoing
Recall initiated
9 Apr 2025
FDA classified
18 Apr 2025
Reported
30 Apr 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter

Timeline

9 Apr 2025Recall initiated by company
18 Apr 2025Classified by FDA+9 days
30 Apr 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations

Product as listed by the FDA

Hemopropin Ointment, Lanolin 17.76% and Petrolatum 71.2%, Net Wt. 0.7 oz (20g) tubes, Manufactured by: Apipharma d.o.o, Croatia, Distributed by: Apipharma, LLC, Tempe, AZ UPC 3 858882 103534 and UPC 3 858882 101318

Where it was distributed

AZ

Arizona

Questions about this recall

Why was it recalled?

CGMP Deviations

Which lots are affected?

Lot #: A00001, Exp.: 2027-12; A00005, Exp.: 2027-01; B00001, Exp.:2028-02

Where was it sold?

AZ

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 96601

More recalls from Apipharma

All 2